Target intelligence / Profile preview

Laetiporus sulphureus lectin N-terminal ricin-B-like domain (LSL-N)

Target
LSL-N
Molecular classification
Lectin, Ricin B-like domain, Pore-forming toxin component
01

Overview

The N-terminal ricin-B domain of LSLa (Laetiporus sulphureus lectin) is a carbohydrate-binding module found in the hemolytic toxin produced by the mushroom Laetiporus sulphureus (Tateno & Goldstein, 2003). This domain adopts a beta-trefoil fold, characteristic of the ricin-B family, and is responsible for the specific recognition and binding of the toxin to cell surface glycoconjugates containing galactose or N-acetylgalactosamine (Mancheño et al., 2005). While the C-terminal domain of LSLa is responsible for membrane insertion and pore formation, the N-terminal domain is crucial for targeting the toxin to the host cell membrane (UniProt P83406). In a research context, this domain is studied for its potential in glycan profiling and as a delivery vehicle for targeting specific cell types, although it is not a conventional therapeutic target. Its primary biological role is as a component of a fungal defense or predatory toxin that induces hemolysis and cell death. There are currently no approved drugs targeting this domain, but small-molecule carbohydrates can act as competitive inhibitors of its binding activity in experimental settings. Structural studies have revealed that the domain forms a hexameric assembly in the context of the full toxin, which is essential for its pore-forming efficiency.

Other names
LSLa N-terminal domainLSL lectin domainRicin-B-like domain of Laetiporus sulphureus lectinLSLa-N
02

Mechanism of action

Competitive inhibition of carbohydrate binding by specific sugars such as lactose or N-acetylgalactosamine

03

Biological functions

Carbohydrate bindingCell adhesionHemagglutination
04

Disease associations

Fungal poisoningHemolysis
05

Safety considerations

CytotoxicityHemolytic activityImmunogenicity

Beyond the preview

Go deeper on Laetiporus sulphureus lectin N-terminal ricin-B-like domain (LSL-N).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laetiporus sulphureus lectin N-terminal ricin-B-like domain (LSL-N).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call